BRPI0813412A2 - Derivados de benzimidazol - Google Patents

Derivados de benzimidazol

Info

Publication number: BRPI0813412A2
Authority: BR; Brazil
Prior art keywords: benzimidazole derivatives; benzimidazole; derivatives
Prior art date: 2007-06-29

Application number

BRPI0813412-0A2A

Other languages

English (en)

Inventor

Christopher Scott Jones

Susan La Greca

Qifang Li

Michael John Munchhof

Lawrence Alan Reiter

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-29

Filing date

2008-06-16

Publication date

2014-12-30

2008-06-16 Application filed by Pfizer filed Critical Pfizer

2014-12-30 Publication of BRPI0813412A2 publication Critical patent/BRPI0813412A2/pt

2020-01-21 Publication of BRPI0813412B1 publication Critical patent/BRPI0813412B1/pt

2021-05-25 Publication of BRPI0813412B8 publication Critical patent/BRPI0813412B8/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0813412A 2007-06-29 2008-06-16 derivados de benzimidazol, seu uso e composição farmacêutica que os compreende BRPI0813412B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US94728707P	2007-06-29	2007-06-29
US4164508P	2008-04-02	2008-04-02
PCT/IB2008/001575 WO2009004427A2 (en)	2007-06-29	2008-06-16	Benzimidazole derivatives

Publications (3)

Publication Number	Publication Date
BRPI0813412A2 true BRPI0813412A2 (pt)	2014-12-30
BRPI0813412B1 BRPI0813412B1 (pt)	2020-01-21
BRPI0813412B8 BRPI0813412B8 (pt)	2021-05-25

Family

ID=40161351

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0813412A BRPI0813412B8 (pt)	2007-06-29	2008-06-16	derivados de benzimidazol, seu uso e composição farmacêutica que os compreende

Country Status (45)

Country	Link
US (2)	US8148401B2 (pt)
EP (1)	EP2170860B9 (pt)
JP (2)	JP4567099B2 (pt)
KR (1)	KR101143246B1 (pt)
CN (1)	CN101687841B (pt)
AP (1)	AP2377A (pt)
AR (1)	AR067346A1 (pt)
AU (1)	AU2008272641B2 (pt)
BR (1)	BRPI0813412B8 (pt)
CA (1)	CA2690953C (pt)
CL (1)	CL2008001922A1 (pt)
CO (1)	CO6160232A2 (pt)
CR (1)	CR11150A (pt)
CU (1)	CU23847B1 (pt)
CY (2)	CY1118650T1 (pt)
DK (1)	DK2170860T5 (pt)
DO (1)	DOP2009000278A (pt)
EA (1)	EA016888B1 (pt)
EC (1)	ECSP099803A (pt)
ES (1)	ES2609258T3 (pt)
FR (1)	FR20C1038I2 (pt)
GE (1)	GEP20125702B (pt)
GT (1)	GT200900328A (pt)
HN (1)	HN2008000974A (pt)
HR (1)	HRP20161562T2 (pt)
HU (2)	HUE030052T4 (pt)
IL (1)	IL202420A (pt)
LT (2)	LT2170860T (pt)
MA (1)	MA31466B1 (pt)
ME (1)	ME00962B (pt)
MY (1)	MY148636A (pt)
NI (1)	NI200900219A (pt)
NL (1)	NL301057I2 (pt)
NO (1)	NO2020027I1 (pt)
NZ (1)	NZ581889A (pt)
PA (1)	PA8785401A1 (pt)
PE (2)	PE20121010A1 (pt)
PL (1)	PL2170860T3 (pt)
PT (1)	PT2170860T (pt)
RS (1)	RS55395B9 (pt)
SI (1)	SI2170860T1 (pt)
TN (1)	TN2009000544A1 (pt)
TW (1)	TWI371451B (pt)
UY (1)	UY31164A1 (pt)
WO (1)	WO2009004427A2 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101687841B (zh) *	2007-06-29	2013-07-10	辉瑞大药厂	苯并咪唑衍生物
CA2735593C (en)	2008-09-03	2017-08-15	Repligen Corporation	Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
MX2011013294A (es) *	2009-06-11	2012-01-12	Siena Biotech Spa	Antagonistas de la trayectoria de hedgehog y aplicaciones terapeuticas de los mismos.
GEP20146075B (en)	2009-08-26	2014-04-10	Takeda Pharmaceuticals Co	Fused heterocyclic ring derivative and usage thereof
US8628554B2 (en)	2010-06-13	2014-01-14	Virender K. Sharma	Intragastric device for treating obesity
US10420665B2 (en)	2010-06-13	2019-09-24	W. L. Gore & Associates, Inc.	Intragastric device for treating obesity
US10010439B2 (en)	2010-06-13	2018-07-03	Synerz Medical, Inc.	Intragastric device for treating obesity
US9526648B2 (en)	2010-06-13	2016-12-27	Synerz Medical, Inc.	Intragastric device for treating obesity
EP2630134B9 (en)	2010-10-20	2018-04-18	Pfizer Inc	Pyridine-2- derivatives as smoothened receptor modulators
JP5452459B2 (ja)	2010-12-16	2014-03-26	株式会社Ｎｔｔドコモ	ホーム基地局及びハンドオーバ方法
JP6250403B2 (ja)	2011-02-28	2017-12-20	バイオマリンファーマシューティカルインク	ヒストン脱アセチル化酵素阻害剤
US10059723B2 (en)	2011-02-28	2018-08-28	Biomarin Pharmaceutical Inc.	Histone deacetylase inhibitors
US8957066B2 (en)	2011-02-28	2015-02-17	Biomarin Pharmaceutical Inc.	Histone deacetylase inhibitors
US9051305B2 (en)	2011-03-08	2015-06-09	Eutropics Pharmaceuticals, Inc.	Compositions and methods useful for treating diseases
FR2980477B1 (fr)	2011-09-23	2013-10-18	Centre Nat Rech Scient	Nouveaux composes modulateurs de la voie de signalisation des proteines hedgehog, leurs formes marquees, et applications
ES2612934T3 (es) *	2011-09-26	2017-05-19	Merck Patent Gmbh	Compuestos de piperidin bencilo como antagonista del receptor del ácido lisofosfatídico (LPA)
US20150133450A1 (en)	2012-06-20	2015-05-14	Eutropics Pharmaceuticals, Inc.	Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
EP2922544B1 (en)	2012-11-21	2018-08-01	Eutropics Pharmaceuticals, Inc.	Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
BR112015023399A8 (pt)	2013-03-15	2019-12-03	Biomarin Pharm Inc	inibidores de hdac, seu uso e composição farmacêutica
EP2996689A1 (en) *	2013-04-17	2016-03-23	Albert-Ludwigs-Universität Freiburg	Compounds for use as bromodomain inhibitors
US10732182B2 (en)	2013-08-01	2020-08-04	Eutropics Pharmaceuticals, Inc.	Method for predicting cancer sensitivity
GB2519344A (en) *	2013-10-18	2015-04-22	Redx Pharma Ltd	Compounds
AU2014342269B2 (en)	2013-10-30	2020-02-27	Eutropics Pharmaceuticals, Inc.	Methods for determining chemosensitivity and chemotoxicity
SG11201707863QA (en) *	2015-04-24	2017-11-29	Pfizer	Crystalline forms of 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate
US10779980B2 (en)	2016-04-27	2020-09-22	Synerz Medical, Inc.	Intragastric device for treating obesity
ES2973822T3 (es)	2020-01-28	2024-06-24	Assia Chem Ind Ltd	Procesos para la preparación de Glasdegib y su sal, y formas en estado sólido de maleato de Glasdegib y proceso para la preparación del mismo
CN113248475B (zh) *	2020-02-11	2023-03-17	中国科学院上海药物研究所	一类杂环取代的苯并咪唑二聚体或其药学上可接受的盐、组合物及其用途
WO2021191278A1 (en)	2020-03-26	2021-09-30	Lek Pharmaceuticals D.D.	Dimaleate form of 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea
US20230301950A1 (en)	2020-06-26	2023-09-28	Raqualia Pharma Inc.	Method for selecting cancer patients for whom combination therapy with retinoid and cancer therapeutic agent is effective, and combination medicament with retinoid and cancer therapeutic agent
WO2023002362A1 (en)	2021-07-22	2023-01-26	Pfizer Inc.	Treatment of hematological malignancy

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ530580A (en)	2001-07-27	2007-02-23	Curis Inc	Mediators of hedgehog signaling pathways, compositions and uses related thereto
SI1499607T1 (sl) *	2001-12-04	2006-06-30	Actelion Pharmaceuticals Ltd	4-(piperidil- in pirolidil-alkil-ureido)-kinolinikot antagonisti receptorja urotensina II
TW200304820A (en) *	2002-03-25	2003-10-16	Avanir Pharmaceuticals	Use of benzimidazole analogs in the treatment of cell proliferation
WO2004035549A1 (en)	2002-10-17	2004-04-29	Amgen Inc.	Benzimidazole derivatives and their use as vanilloid receptor ligands
WO2005042495A1 (en)	2003-10-21	2005-05-12	Imclone Systems Incorporated	(benzimidazol-2-yl)-phenyl-phenyl-urea compounds and methods for inhibiting heparanase activity
WO2005042497A2 (en)	2003-10-28	2005-05-12	Vertex Pharmaceuticals, Incorporated	Benzimidazoles useful as modulators of ion channels
EP1807074B1 (en)	2004-11-03	2013-10-23	Curis, Inc.	Mediators of hedgehog signaling pathways, compositions and uses related thereto
DE102005012875B4 (de) *	2005-03-19	2006-11-16	Sanofi-Aventis Deutschland Gmbh	Verwendung von Amino substituierten 8-N-Benzimidazolen
WO2006124780A2 (en) *	2005-05-12	2006-11-23	Kalypsys, Inc.	Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase
WO2008064830A1 (en)	2006-11-27	2008-06-05	Ucb Pharma, S.A.	Bicyclic and heterobicyclic derivatives, processes for preparing them and their pharmaceutical uses
EP2121626A1 (en)	2006-12-15	2009-11-25	Pfizer Products Inc.	Benzimidazole derivatives
CN101687841B (zh)	2007-06-29	2013-07-10	辉瑞大药厂	苯并咪唑衍生物
EP2303275A4 (en)	2008-06-17	2012-05-09	Univ Duke	STANDARD RECEPTOR MODULATORS
JP5555236B2 (ja)	2008-08-25	2014-07-23	アイアールエム・リミテッド・ライアビリティ・カンパニー	ヘッジホッグ経路モジュレーター

2008
- 2008-06-16 CN CN200880022602XA patent/CN101687841B/zh active Active
- 2008-06-16 AP AP2009005089A patent/AP2377A/xx active
- 2008-06-16 BR BRPI0813412A patent/BRPI0813412B8/pt active IP Right Grant
- 2008-06-16 KR KR1020107001991A patent/KR101143246B1/ko active Active
- 2008-06-16 LT LTEP08762901.0T patent/LT2170860T/lt unknown
- 2008-06-16 ES ES08762901.0T patent/ES2609258T3/es active Active
- 2008-06-16 RS RS20161132A patent/RS55395B9/sr unknown
- 2008-06-16 GE GEAP200811622A patent/GEP20125702B/en unknown
- 2008-06-16 EA EA200971104A patent/EA016888B1/ru unknown
- 2008-06-16 WO PCT/IB2008/001575 patent/WO2009004427A2/en not_active Ceased
- 2008-06-16 SI SI200831707A patent/SI2170860T1/sl unknown
- 2008-06-16 ME MEP-2009-349A patent/ME00962B/me unknown
- 2008-06-16 CA CA2690953A patent/CA2690953C/en active Active
- 2008-06-16 PL PL08762901T patent/PL2170860T3/pl unknown
- 2008-06-16 MY MYPI20095266A patent/MY148636A/en unknown
- 2008-06-16 JP JP2010514162A patent/JP4567099B2/ja active Active
- 2008-06-16 AU AU2008272641A patent/AU2008272641B2/en active Active
- 2008-06-16 EP EP08762901.0A patent/EP2170860B9/en active Active
- 2008-06-16 NZ NZ581889A patent/NZ581889A/en unknown
- 2008-06-16 HU HUE08762901A patent/HUE030052T4/en unknown
- 2008-06-16 DK DK08762901.0T patent/DK2170860T5/en active
- 2008-06-16 PT PT87629010T patent/PT2170860T/pt unknown
- 2008-06-16 HR HRP20161562TT patent/HRP20161562T2/hr unknown
- 2008-06-19 PA PA20088785401A patent/PA8785401A1/es unknown
- 2008-06-19 US US12/142,119 patent/US8148401B2/en active Active
- 2008-06-20 UY UY31164A patent/UY31164A1/es active IP Right Grant
- 2008-06-25 HN HN2008000974A patent/HN2008000974A/es unknown
- 2008-06-27 TW TW097124392A patent/TWI371451B/zh active
- 2008-06-27 PE PE2012000473A patent/PE20121010A1/es active IP Right Grant
- 2008-06-27 CL CL2008001922A patent/CL2008001922A1/es unknown
- 2008-06-27 AR ARP080102792A patent/AR067346A1/es active IP Right Grant
- 2008-06-27 PE PE2008001105A patent/PE20090772A1/es active IP Right Grant
2009
- 2009-11-30 IL IL202420A patent/IL202420A/en active IP Right Grant
- 2009-12-07 CR CR11150A patent/CR11150A/es unknown
- 2009-12-08 DO DO2009000278A patent/DOP2009000278A/es unknown
- 2009-12-14 EC EC2009009803A patent/ECSP099803A/es unknown
- 2009-12-18 NI NI200900219A patent/NI200900219A/es unknown
- 2009-12-21 GT GT200900328A patent/GT200900328A/es unknown
- 2009-12-21 CU CU2009000225A patent/CU23847B1/es active IP Right Grant
- 2009-12-23 CO CO09147462A patent/CO6160232A2/es unknown
- 2009-12-25 TN TNP2009000544A patent/TN2009000544A1/fr unknown
- 2009-12-29 MA MA32454A patent/MA31466B1/fr unknown
2010
- 2010-08-04 JP JP2010175465A patent/JP2010280693A/ja active Pending
2012
- 2012-02-24 US US13/404,169 patent/US8431597B2/en active Active
2016
- 2016-12-14 CY CY20161101293T patent/CY1118650T1/el unknown
2020
- 2020-07-15 NL NL301057C patent/NL301057I2/nl unknown
- 2020-08-11 NO NO2020027C patent/NO2020027I1/no unknown
- 2020-08-12 CY CY2020028C patent/CY2020028I1/el unknown
- 2020-08-13 HU HUS2000031C patent/HUS2000031I1/hu unknown
- 2020-08-20 FR FR20C1038C patent/FR20C1038I2/fr active Active
- 2020-08-26 LT LTPA2020528C patent/LTC2170860I2/lt unknown

Also Published As

Publication number	Publication date
GEP20125702B (en)	2012-12-10
LTC2170860I2 (lt)	2022-03-10
MA31466B1 (fr)	2010-06-01
ME00962B (me)	2012-06-20
US20090005416A1 (en)	2009-01-01
IL202420A0 (en)	2010-06-30
AP2377A (en)	2012-03-07
BRPI0813412B8 (pt)	2021-05-25
NO2020027I1 (no)	2020-08-11
NL301057I1 (nl)	2020-07-22
PT2170860T (pt)	2017-01-04
BRPI0813412B1 (pt)	2020-01-21
CY2020028I2 (el)	2020-11-25
GT200900328A (es)	2011-08-29
US8148401B2 (en)	2012-04-03
ECSP099803A (es)	2010-01-29
CA2690953A1 (en)	2009-01-08
JP2010280693A (ja)	2010-12-16
CO6160232A2 (es)	2010-05-20
FR20C1038I2 (fr)	2021-08-13
HK1139658A1 (en)	2010-09-24
EA200971104A1 (ru)	2010-06-30
DK2170860T3 (en)	2017-01-09
PL2170860T3 (pl)	2017-05-31
KR20100028120A (ko)	2010-03-11
AU2008272641B2 (en)	2013-08-29
ES2609258T3 (es)	2017-04-19
WO2009004427A3 (en)	2009-06-04
TW200911792A (en)	2009-03-16
EP2170860A2 (en)	2010-04-07
UY31164A1 (es)	2009-01-30
HRP20161562T1 (hr)	2016-12-30
TN2009000544A1 (fr)	2011-03-31
NI200900219A (es)	2010-03-11
PE20090772A1 (es)	2009-06-24
US8431597B2 (en)	2013-04-30
HRP20161562T2 (hr)	2017-04-21
KR101143246B1 (ko)	2012-05-18
PA8785401A1 (es)	2009-01-23
MY148636A (en)	2013-05-15
RS55395B9 (sr)	2020-01-31
LT2170860T (lt)	2017-01-10
AU2008272641A1 (en)	2009-01-08
CR11150A (es)	2010-02-08
EP2170860B1 (en)	2016-11-02
IL202420A (en)	2014-05-28
EA016888B1 (ru)	2012-08-30
NZ581889A (en)	2011-05-27
AP2009005089A0 (en)	2009-12-31
JP4567099B2 (ja)	2010-10-20
HUE030052T4 (en)	2017-06-28
CY2020028I1 (el)	2020-11-25
FR20C1038I1 (pt)	2020-10-02
PE20121010A1 (es)	2012-08-06
HN2008000974A (es)	2011-01-24
AR067346A1 (es)	2009-10-07
DK2170860T5 (en)	2017-03-20
US20120157495A1 (en)	2012-06-21
CN101687841B (zh)	2013-07-10
HUE030052T2 (hu)	2017-04-28
WO2009004427A2 (en)	2009-01-08
RS55395B1 (sr)	2017-04-28
DOP2009000278A (es)	2009-12-31
TWI371451B (en)	2012-09-01
HUS2000031I1 (hu)	2020-09-28
EP2170860B9 (en)	2017-02-22
SI2170860T1 (sl)	2017-01-31
CN101687841A (zh)	2010-03-31
CL2008001922A1 (es)	2009-01-02
JP2010531869A (ja)	2010-09-30
CA2690953C (en)	2012-10-02
NL301057I2 (nl)	2020-09-10
CU23847B1 (es)	2012-10-15
LTPA2020528I1 (lt)	2020-09-25
CU20090225A7 (es)	2012-02-15
CY1118650T1 (el)	2017-07-12

Publication	Publication Date	Title
LTPA2020528I1 (lt)	2020-09-25	Benzimidazolo dariniai
BR112012010502A2 (pt)	2016-03-15	derivados de benzimidazol-imidazol
DK2164844T3 (da)	2012-08-20	Pyrimidinyl-pyridazinonderivater
DK2209786T3 (da)	2013-06-03	Pyrimidinsubstituerede purinderivater
BRPI0820112A2 (pt)	2015-05-05	Derivados de isoxazol-piridina
BRPI0809992A2 (pt)	2014-10-14	Derivados de pirrolopirimidina
DK2308877T3 (da)	2014-04-22	Imidazopyridin-2-on-derivater
BRPI0820113A2 (pt)	2015-05-05	Derivados de isoxazolo-piridazina
BRPI0813836A2 (pt)	2015-01-06	Derivados pirazólicos
BRPI0812155A2 (pt)	2019-09-24	derivados de espiroindolinona
BRPI0817935A2 (pt)	2015-04-07	Derivados de biarila
BRPI0821315A2 (pt)	2019-09-24	compostos benzimidazol
ATE518837T1 (de)	2011-08-15	Indazolamidderivate
BRPI0814236A2 (pt)	2015-01-06	Derivados de quinazolinamida
ATE533761T1 (de)	2011-12-15	Imidazolidinonderivate
BRPI0820649A2 (pt)	2015-06-16	Derivados de isoxazalo-pirazina
DK2152370T3 (da)	2011-08-15	Aryletherpyridazinonderivater
DK2275414T3 (da)	2015-06-22	Cyclopentylacrylamidderivat
BRPI0913234A2 (pt)	2016-01-19	derivados de tiazolilpiperidina
IL209733A0 (en)	2011-02-28	New benzimidazole derivatives
ATE519760T1 (de)	2011-08-15	Isoxazolimidazolderivate
ATE534634T1 (de)	2011-12-15	2-phenyl-4-cyclopropyl-pyrimidinderivate
BRPI0811214A2 (pt)	2014-10-29	Derivados de pirazolona
ATE467626T1 (de)	2010-05-15	Indol-2-yl-piperazin-1-yl-methanon-derivate
DK2167469T3 (da)	2012-11-12	Sulfonylquinolinderivater

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-02-12	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-03-26	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-09-10	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2019-12-03	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-01-21	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/01/2020, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/06/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2023-07-25	B25G	Requested change of headquarter approved	Owner name: PFIZER INC. (US)